Streetbeat News

Analyst Ratings

HZNP

Horizon Therapeutics Inc.'s stock has increased by 14.13% over the past month and by 85.79% over the past year. The company's P/E ratio of 59.89 is higher than the Biotechnology industry's aggregate P/E ratio of 40.29, which could indicate that the stock is overvalued or that it might perform better than its industry group.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 6:15 pm

AKAM

Citigroup analyst Fatima Boolani maintains a Neutral rating on Akamai Techs (NASDAQ:AKAM) and raises the price target from $98 to $105.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 6:03 pm

LULU

Wedbush analyst Tom Nikic has reiterated an Outperform rating on Lululemon Athletica Inc (NASDAQ:LULU) with a price target of $415. Despite a challenging macro environment, the analyst believes LULU's 100% DTC model and lack of exposure to the wholesale channel allows it to maintain pricing discipline and avoid promotional pressure. The company's strong product offering continues to resonate with consumers, and it has been prudently conservative in its guidance, allowing for continued 'beat-and-raise' performance.

Portfolio Pulse from Shivani Kumaresan

August 30, 2023 | 6:03 pm

APLS

Citigroup analyst Yigal Nochomovitz maintains a 'Buy' rating on Apellis Pharmaceuticals and raises the price target from $45 to $54.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 6:02 pm

AVPT

Citigroup analyst Fatima Boolani has maintained a Neutral rating on AvePoint (NASDAQ:AVPT) and raised the price target from $5.8 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 6:01 pm

FSLY

Over the past 3 months, 5 analysts have published their opinion on Fastly (NYSE:FSLY) stock. The company has an average price target of $13.6 with a high of $19.00 and a low of $10.00. The average price target has increased by 13.33% over the past month.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 6:01 pm

NET

Over the past 3 months, 16 analysts have published their opinion on Cloudflare (NYSE:NET) stock. The average 12-month price target for Cloudflare is $66.25, with a high of $85.00 and a low of $43.00. This average price target has increased by 12.88% over the past month.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 6:01 pm

ARKK

ARKQ

ARKW

TSLA

Cathie Wood, CEO of Ark Invest, believes that Tesla should be valued as a high-growth tech stock rather than an automotive stock due to its operations in fields like solar, energy storage, AI, autonomous driving, and robotics. Wood compared Tesla's decision to design its own chip for autonomous driving to Apple's move to create its own chip, which transformed the cell phone market. Tesla remains a top-five holding in Ark Innovation ETF, Ark Next Generation Internet ETF, and Ark Autonomous Technology & Robotics ETF.

Portfolio Pulse from Chris Katje

August 30, 2023 | 6:00 pm

KRC

In the last quarter, Kilroy Realty (NYSE:KRC) received 1 bullish, 1 somewhat bullish, and 2 indifferent ratings from analysts. The company's average 12-month price target is $39.5, up 3.95% from the previous average of $38.00.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 6:00 pm

WPC

Over the past 3 months, 6 analysts have published their opinion on W.P. Carey (NYSE:WPC) stock. The average price target is $74.5, implying an upside from the current price of $65.1. However, this average has decreased by 8.02% from the previous average price target of $81.00.

Portfolio Pulse from Benzinga Insights

August 30, 2023 | 6:00 pm